We are live on ! Find out more
ZYME icon

Zymeworks

171 hedge funds and large institutions have $713M invested in Zymeworks in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 65 increasing their positions, 39 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 17

67% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 39

21% more call options, than puts

Call options by funds: $906K | Put options by funds: $750K

9% more funds holding

Funds holding: 157171 (+14)

2% less capital invested

Capital invested by funds: $724M → $713M (-$11.5M)

3.56% less ownership

Funds ownership: 99.61%96.05% (-3.6%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
171
Holders Change
+14
Holders Change %
+8.92%
% of All Funds
2.46%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
32
Increased
65
Reduced
39
Closed
17
Calls
$906K
Puts
$750K
Net Calls
+$156K
Net Calls Change
-$647K

ZYME Hedge Fund Activity: Q1 2024 in Review

171 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2024, worth a combined $713M — down 1.6% from $724M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ZYME positions and 17 closed out — a net gain of 15 holders — while 65 added to existing stakes and 39 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $9.9M. The largest seller was Morgan Stanley, cutting an estimated $51.2M.

  • 171 institutional investors held Zymeworks (ZYME) as of Q1 2024, up from 157 in Q4 2023.
  • Funds reported $713M of Zymeworks stock for Q1 2024, down 1.6% quarter-over-quarter.
  • 32 funds opened new Zymeworks positions in Q1 2024 and 17 closed out, a net change of +15 holders.
  • The largest Zymeworks buyer in Q1 2024 was Citadel Advisors, an estimated $9.9M added.
  • The largest Zymeworks seller in Q1 2024 was Morgan Stanley, an estimated $51.2M sold.

Based on aggregated 13F filings for Q1 2024.